These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1086 related articles for article (PubMed ID: 26451651)
1. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase. Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651 [TBL] [Abstract][Full Text] [Related]
2. 2-Furoic piperazide derivatives as promising drug candidates of type 2 diabetes and Alzheimer's diseases: In vitro and in silico studies. Abbasi MA; Hassan M; Ur-Rehman A; Siddiqui SZ; Hussain G; Shah SAA; Ashraf M; Shahid M; Seo SY Comput Biol Chem; 2018 Dec; 77():72-86. PubMed ID: 30245349 [TBL] [Abstract][Full Text] [Related]
3. Novel pyridine-2,4,6-tricarbohydrazide thiourea compounds as small key organic molecules for the potential treatment of type-2 diabetes mellitus: In vitro studies against yeast α- and β-glucosidase and in silico molecular modeling. Rehman TU; Riaz S; Khan IU; Ashraf M; Bajda M; Gawalska A; Yar M Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29194730 [TBL] [Abstract][Full Text] [Related]
4. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies. Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of some new N-(alkyl/aralkyl)-N-(2,3-dihydro-1,4-benzodioxan-6-yl)-4-chlorobenzenesulfonamides as possible therapeutic agents for Alzheimer's disease and Type-2 Diabetes. Abbasi MA; Rehman A; Siddiqui SZ; Hadi N; Mumtaz A; Shah SAA; Ashraf M; Abbasi GH Pak J Pharm Sci; 2019 Jan; 32(1):61-68. PubMed ID: 30772791 [TBL] [Abstract][Full Text] [Related]
6. Exploring fluorine-substituted piperidines as potential therapeutics for diabetes mellitus and Alzheimer's diseases. Mughal EU; Hawsawi MB; Naeem N; Hassan A; Alluhaibi MS; Ali Shah SW; Nazir Y; Sadiq A; Alrafai HA; Ahmed SA Eur J Med Chem; 2024 Jul; 273():116523. PubMed ID: 38795518 [TBL] [Abstract][Full Text] [Related]
7. In Vitro and Molecular Docking Evaluation of the Anticholinesterase and Antidiabetic Effects of Compounds from Feunaing RT; Tamfu AN; Gbaweng AJY; Kucukaydin S; Tchamgoue J; Lannang AM; Lenta BN; Kouam SF; Duru ME; Anouar EH; Talla E; Dinica RM Molecules; 2024 May; 29(11):. PubMed ID: 38893333 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, Characterization, and Inhibition Study of Novel Substituted Phenylureido Sulfaguanidine Derivatives as α-Glycosidase and Cholinesterase Inhibitors. Akocak S; Taslimi P; Lolak N; Işık M; Durgun M; Budak Y; Türkeş C; Gülçin İ; Beydemir Ş Chem Biodivers; 2021 Apr; 18(4):e2000958. PubMed ID: 33620128 [TBL] [Abstract][Full Text] [Related]
9. Assessment of Anticholinergic and Antidiabetic Properties of Some Natural and Synthetic Molecules: An Çomaklı V; Aygül İ; Sağlamtaş R; Kuzu M; Demirdağ R; Akincioğlu H; Adem Ş; Gülçin İ Curr Comput Aided Drug Des; 2024; 20(5):441-451. PubMed ID: 37202895 [TBL] [Abstract][Full Text] [Related]
10. An Efficient Synthesis of bi-Aryl Pyrimidine Heterocycles: Potential New Drug Candidates to Treat Alzheimer's Disease. Rehman TU; Khan IU; Ashraf M; Tarazi H; Riaz S; Yar M Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28220522 [TBL] [Abstract][Full Text] [Related]
11. Comparative Cholinesterase, α-Glucosidase Inhibitory, Antioxidant, Molecular Docking, and Kinetic Studies on Potent Succinimide Derivatives. Ahmad A; Ullah F; Sadiq A; Ayaz M; Saeed Jan M; Shahid M; Wadood A; Mahmood F; Rashid U; Ullah R; Sahibzada MUK; Alqahtani AS; Mahmood HM Drug Des Devel Ther; 2020; 14():2165-2178. PubMed ID: 32606589 [TBL] [Abstract][Full Text] [Related]
12. Probing benzenesulfonamide-thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: α-glucosidase and carbonic anhydrase II. Gamal MA; Fahim SH; Giovannuzzi S; Fouad MA; Bonardi A; Gratteri P; Supuran CT; Hassan GS Eur J Med Chem; 2024 May; 271():116434. PubMed ID: 38653067 [TBL] [Abstract][Full Text] [Related]
13. Novel pyridine-2,4,6-tricarbohydrazide derivatives: design, synthesis, characterization and in vitro biological evaluation as α- and β-glucosidase inhibitors. Riaz S; Khan IU; Yar M; Ashraf M; Rehman TU; Shaukat A; Jamal SB; Duarte VCM; Alves MJ Bioorg Chem; 2014 Dec; 57():148-154. PubMed ID: 25462991 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, molecular docking, and biological activities of new cyanopyridine derivatives containing phenylurea. Gezegen H; Gürdere MB; Dinçer A; Özbek O; Koçyiğit ÜM; Taslimi P; Tüzün B; Budak Y; Ceylan M Arch Pharm (Weinheim); 2021 Apr; 354(4):e2000334. PubMed ID: 33300644 [TBL] [Abstract][Full Text] [Related]
15. New 6-amino-pyrido[2,3-d]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α-glucosidase inhibition, molecular modeling and kinetic study. Adib M; Peytam F; Rahmanian-Jazi M; Mahernia S; Bijanzadeh HR; Jahani M; Mohammadi-Khanaposhtani M; Imanparast S; Faramarzi MA; Mahdavi M; Larijani B Eur J Med Chem; 2018 Jul; 155():353-363. PubMed ID: 29902721 [TBL] [Abstract][Full Text] [Related]
16. Explore new quinoxaline pharmacophore tethered sulfonamide fragments as in vitro α-glucosidase, α-amylase, and acetylcholinesterase inhibitors with ADMET and molecular modeling simulation. Ragab A; Salem MA; Ammar YA; Aboulthana WM; Helal MH; Abusaif MS Drug Dev Res; 2024 Jun; 85(4):e22216. PubMed ID: 38831547 [TBL] [Abstract][Full Text] [Related]
17. Dual inhibition of the α-glucosidase and butyrylcholinesterase studied by molecular field topology analysis. Jabeen F; Oliferenko PV; Oliferenko AA; Pillai GG; Ansari FL; Hall CD; Katritzky AR Eur J Med Chem; 2014 Jun; 80():228-42. PubMed ID: 24780600 [TBL] [Abstract][Full Text] [Related]
18. Investigations of Limeum Indicum Plant for Diabetes Mellitus and Alzheimer's Disease Dual Therapy: Phytochemical, GC-MS Chemical Profiling, Enzyme Inhibition, Molecular Docking and In-Vivo Studies. Shamim T; Asif HM; Abida Ejaz S; Hussain Z; Wani TA; Sumreen L; Abdullah M; Ahmed Z; Iqbal J; Kim SJ; Shah MK Chem Biodivers; 2024 Jun; 21(6):e202301858. PubMed ID: 38608202 [TBL] [Abstract][Full Text] [Related]
19. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates. Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697 [TBL] [Abstract][Full Text] [Related]
20. Exploration of aroyl/heteroaroyl iminothiazolines featuring 2,4,5-trichlorophenyl moiety as a new class of potent, selective, and in vitro efficacious glucosidase inhibitors. Kazmi M; Zaib S; Amjad ST; Khan I; Ibrar A; Saeed A; Iqbal J Bioorg Chem; 2017 Oct; 74():134-144. PubMed ID: 28780150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]